-
Mashup Score: 3Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial - 5 hour(s) ago
Design of the vericiguat global study in participants with chronic heart failure (VICTOR) trial. GDMT, guideline-directed medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejectio…
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 33Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial - 11 day(s) ago
Design of the vericiguat global study in participants with chronic heart failure (VICTOR) trial. GDMT, guideline-directed medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejectio…
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet-
π₯#VICTOR trial design : #Vericiguat in #Chronic #HFrEF Will be #vericiguat ready to be the 5th pharmacological pillar in #HFrEF #HFUA @ESC_Journals @EJHFEiC @AmrAbdin10 @MicheleEmdin @JJheart_doc @KTamirisaMD @DrRajivsankar @JavedButler1 https://t.co/tTO7E6PPxE https://t.co/PaXLumgqsB https://t.co/hIlAPWEBJH
-
-
Mashup Score: 67Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM - 16 day(s) ago
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
π₯β€οΈβπ₯ #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV β οΈ & Total #HHF π₯ A 2nd pillar for #HFmrEF & #HFpEF has just been built ποΈ #HFUA @EJHFEiC @NEJM @gcfmd @JJheart_doc @AndrewJSauer @BiykemB @MicheleEmdin @iamritu @pabeda1 https://t.co/Rd5af1gdX7 https://t.co/v6Hw0ya5Zh
-
-
Mashup Score: 66Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM - 18 day(s) ago
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
π₯β€οΈβπ₯ #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV β οΈ & Total #HHF π₯ A 2nd pillar for #HFmrEF & #HFpEF has just been built ποΈ #HFUA @EJHFEiC @NEJM @gcfmd @JJheart_doc @AndrewJSauer @BiykemB @MicheleEmdin @iamritu @pabeda1 https://t.co/Rd5af1gdX7 https://t.co/v6Hw0ya5Zh
-
-
Mashup Score: 34The 25in25 initiative: A novel transformative project to reduce mortality due to heart failure by 25% in the next 25βyears - 18 day(s) ago
Click on the article title to read more.
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet-
π₯ The 25in25 initiative : A novel project to reduce #HF β οΈ 25% in the next 25 y #HFprevalence is still raising π¨ Detect the undetected & treat it π #HFUA @ESC_Journals @EJHFEiC @MicheleEmdin @JJheart_doc @KTamirisaMD @DrRajivsankar @AndrewJSauer https://t.co/MMIJOovieS https://t.co/fbLmUWsxcS
-
-
Mashup Score: 67Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM - 22 day(s) ago
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
π₯β€οΈβπ₯ #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV β οΈ & Total #HHF π₯ A 2nd pillar for #HFmrEF & #HFpEF has just been built ποΈ #HFUA @EJHFEiC @NEJM @gcfmd @JJheart_doc @AndrewJSauer @BiykemB @MicheleEmdin @iamritu @pabeda1 https://t.co/Rd5af1gdX7 https://t.co/v6Hw0ya5Zh
-
-
Mashup Score: 2The chronobiology of human heart failure: clinical implications and therapeutic opportunities - PubMed - 1 month(s) ago
Circadian variation in cardiovascular and metabolic dynamics arises from interactions between intrinsic rhythms and extrinsic cues. By anticipating and accommodating adaptation to awakening and activity, their synthesis maintains homeostasis and maximizes efficiency, flexibility, and resilience. The β¦
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 67Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM - 1 month(s) ago
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and m…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
π₯β€οΈβπ₯ #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV β οΈ & Total #HHF π₯ A 2nd pillar for #HFmrEF & #HFpEF has just been built ποΈ #HFUA @EJHFEiC @NEJM @gcfmd @JJheart_doc @AndrewJSauer @BiykemB @MicheleEmdin @iamritu @pabeda1 https://t.co/Rd5af1gdX7 https://t.co/v6Hw0ya5Zh
-
-
Mashup Score: 13Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study - 1 month(s) ago
The RevascHeart study. AHF, acute heart failure; CABG, coronary artery bypass graft; CI, confidence interval; CV, cardiovascular; GDMT, guideline-directed medical therapy; LVEDD, left ventricular end…
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 23Heart Failure - 2 month(s) ago
Return to CVD Roadmaps Home Due to the aging population, increase in cardiovascular risk factors and improved survival of cardiovascular conditions, the prevalence of heart failure is increasing globally to an estimated number of 26 million, with additional millions of undiagnosed cases. Despite the fact that many cardiovascular diseases end in heart failure, the condition too often fails to attract the awareness and emphasis it deserves. Heart failure is a complex clinical syndrome when the heart is
Source: world-heart-federation.orgCategories: General Medicine News, CardiologistsTweet-
π«#WorldHeartDay #CardiovascularDiseases are the 1st cause of β οΈ & #HeartFailure the 1st cause of π₯ globallyπ! Protect #Heart β€οΈ #HFUA https://t.co/SSLBw1nHVZ #UseHeart #HeartYes @SIC_CARDIOLOGIA @_anmco @AnnaKateBarton @FedericaFogacci @MicheleEmdin @KardiologieHH @gcfmd https://t.co/MFlsf4GUAJ
-
π₯#VICTOR trial design : #Vericiguat in #Chronic #HFrEF Will be #vericiguat ready to be the 5th pharmacological pillar in #HFrEF #HFUA @ESC_Journals @EJHFEiC @AmrAbdin10 @MicheleEmdin @JJheart_doc @KTamirisaMD @DrRajivsankar @JavedButler1 https://t.co/tTO7E6PPxE https://t.co/PaXLumgqsB https://t.co/hIlAPWEBJH